Find a Tender
complete
Official procurement procedure
Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published5
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts): "Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)". Published status: complete. Published value: Value not published. 5 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
5.2Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 26 active published awards; 26 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published9 Aug 2024, 15:26 BST | Last source update9 Aug 2024, 15:26 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-04368a | ||
What is being bought
NHS Wales Framework Agreement for the supply of Aseptically Prepared Systemic Anti-Cancer Treatment (SACT)
What changed
From the official release history
- Status changed to complete
9 Aug 2024, 15:26 BST - Official notice release published
9 Aug 2024, 15:26 BST - Submission deadline changed to published date
9 Aug 2024, 15:26 BST - Buyer information updated
9 Aug 2024, 15:26 BST - Status changed to active
1 Feb 2024, 17:34 GMT - Official notice release published
1 Feb 2024, 17:34 GMT - Submission deadline changed to 4 Mar 2024, 12:00 GMT
1 Feb 2024, 17:34 GMT - Buyer information updated
1 Feb 2024, 17:34 GMT
Lots and requirements (5)
Published by the contracting authority
- Lot 1 · #1Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Batch ProductscancelledPublished valueNot publishedCompounded Aseptic MedicinesContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Batch ProductscancelledPublished valueNot publishedCompounded Aseptic products. Additional information: Compounded Aseptic productsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Batch ProductscancelledPublished valueNot publishedCompounded Aseptic products. Additional information: Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Batch ProductsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #4Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Batch ProductscancelledPublished valueNot publishedCompounded Aseptic productsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #5Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) - Patient Specific ProductscancelledPublished valueNot publishedCompounded Aseptic ProductsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
9 Aug 2024, 15:26 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 31 Jul 2024, 00:00 BST · £5,965,196 - Contract active
Signed 31 Jul 2024, 00:00 BST · £5,965,196 - Contract active
Signed 31 Jul 2024, 00:00 BST · £19,145,096 - Contract active
Signed 30 Jul 2024, 00:00 BST · £14,965,348 - Contract active
Signed 30 Jul 2024, 00:00 BST · £19,145,096 - Contract active
Signed 30 Jul 2024, 00:00 BST · £1,945,084 - Contract active
Signed 30 Jul 2024, 00:00 BST · £1,945,084 - Contract active
Signed 30 Jul 2024, 00:00 BST · £1,945,084 - Contract active
Signed 30 Jul 2024, 00:00 BST · £1,945,084 - Contract active
Signed 30 Jul 2024, 00:00 BST · £1,945,084 - Contract active
Signed 30 Jul 2024, 00:00 BST · £5,965,196 - Contract active
Signed 30 Jul 2024, 00:00 BST · £5,965,196 - Contract active
Signed 30 Jul 2024, 00:00 BST · £14,965,348 - Contract active
Signed 30 Jul 2024, 00:00 BST · £5,965,196 - Contract active
Signed 30 Jul 2024, 00:00 BST · £5,965,196 - Contract active
Signed 30 Jul 2024, 00:00 BST · £5,626,851 - Contract active
Signed 30 Jul 2024, 00:00 BST · £5,626,851 - Contract active
Signed 30 Jul 2024, 00:00 BST · £5,626,851 - Contract active
Signed 30 Jul 2024, 00:00 BST · £5,626,851 - Contract active
Signed 30 Jul 2024, 00:00 BST · £5,626,851 - Contract active
Signed 30 Jul 2024, 00:00 BST · £14,965,348 - Contract active
Signed 30 Jul 2024, 00:00 BST · £14,965,348 - Contract active
Signed 30 Jul 2024, 00:00 BST · £14,965,348 - Contract active
Signed 30 Jul 2024, 00:00 BST · £19,145,096 - Contract active
Signed 30 Jul 2024, 00:00 BST · £19,145,096 - Contract active
Signed 30 Jul 2024, 00:00 BST · £19,145,096
Commercial outcome and competition
Awards Qualasept Ltd t/a Bath ASU Not published · Not published · active Lloyds Pharmacy Clinical Homecare Not published · Not published · active Qualasept Ltd t/a Bath ASU Not published · Not published · active Quantum Pharmaceutical Ltd Not published · Not published · active Baxter Healthcare Limited Not published · Not published · active ITH Pharma Ltd Not published · Not published · active Lloyds Pharmacy Clinical Homecare Not published · Not published · active Qualasept Ltd t/a Bath ASU Not published · Not published · active Baxter Healthcare Limited Not published · Not published · active Quantum Pharmaceutical Ltd Not published · Not published · active ITH Pharma Ltd Not published · Not published · active Baxter Healthcare Limited Not published · Not published · active Lloyds Pharmacy Clinical Homecare Not published · Not published · active Sciensus Ltd Not published · Not published · active Qualasept Ltd t/a Bath ASU Not published · Not published · active Baxter Healthcare Limited Not published · Not published · active Quantum Pharmaceutical Ltd Not published · Not published · active ITH Pharma Ltd Not published · Not published · active Lloyds Pharmacy Clinical Homecare Not published · Not published · active Quantum Pharmaceutical Ltd Not published · Not published · active ITH Pharma Ltd Not published · Not published · active Lloyds Pharmacy Clinical Homecare Not published · Not published · active Qualasept Ltd t/a Bath ASU Not published · Not published · active Baxter Healthcare Limited Not published · Not published · active Quantum Pharmaceutical Ltd Not published · Not published · active ITH Pharma Ltd Not published · Not published · active |
Contracts Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £5,965,196 · signed 31 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £5,965,196 · signed 31 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £19,145,096 · signed 31 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £14,965,348 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £19,145,096 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £1,945,084 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £1,945,084 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £1,945,084 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £1,945,084 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £1,945,084 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £5,965,196 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £5,965,196 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £14,965,348 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £5,965,196 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £5,965,196 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £5,626,851 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £5,626,851 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £5,626,851 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £5,626,851 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £5,626,851 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £14,965,348 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £14,965,348 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £14,965,348 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £19,145,096 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £19,145,096 · signed 30 Jul 2024, 00:00 BST · active Aseptically Prepared Systemic Anti-Cancer Treatment (SACT) £19,145,096 · signed 30 Jul 2024, 00:00 BST · active |
Bid statistics bids: 5 (lot 1) bids: 5 (lot 1) bids: 5 (lot 1) bids: 5 (lot 1) bids: 5 (lot 1) bids: 5 (lot 2) bids: 5 (lot 2) bids: 5 (lot 2) bids: 5 (lot 2) bids: 5 (lot 2) bids: 5 (lot 3) bids: 5 (lot 3) bids: 5 (lot 3) bids: 5 (lot 3) bids: 5 (lot 3) bids: 6 (lot 4) bids: 6 (lot 4) bids: 6 (lot 4) bids: 6 (lot 4) bids: 6 (lot 4) bids: 6 (lot 4) bids: 5 (lot 5) bids: 5 (lot 5) bids: 5 (lot 5) bids: 5 (lot 5) bids: 5 (lot 5) |
Buyer and organisations in this procedure
Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
Contracting authority GB-FTS-121161Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published